TWC
BLTE

TD Waterhouse Canada’s Belite Bio BLTE Stock Holding History

TD Waterhouse Canada’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-70
Closed -$11.7K – 2420
2026
Q1 		$11.7K Hold
70
– – ﹤0.01% 1717
2025
Q4 		$11.2K Buy
+70
New +$8.29K ﹤0.01% 1520

Other funds holding BLTE

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HNWAG
High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
RF
Rossby Financial Melbourne, Florida $547M AUM 30.65% 1-Year Est. Return

TD Waterhouse Canada's BLTE Position: Q2 2026 in Review

TD Waterhouse Canada sold out of Belite Bio (BLTE) in Q2 2026, closing a stake of 70 shares — an estimated $11.7K sold.

TD Waterhouse Canada first reported a position in BLTE in Q4 2025 and held it in 2 quarters. The position peaked at $11.7K in Q1 2026. 13 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • TD Waterhouse Canada reported no remaining Belite Bio position as of Q2 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 70 Belite Bio shares in Q2 2026, an estimated $11.7K.
  • TD Waterhouse Canada first reported a position in Belite Bio in Q4 2025 and held it in 2 quarters.
  • TD Waterhouse Canada's Belite Bio position peaked at $11.7K in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.